Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for NSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 49.33M
March 31, 2026 49.33M
December 31, 2025 46.88M
September 30, 2025 46.88M
June 30, 2025 46.88M
March 31, 2025 46.88M
December 31, 2024 46.88M
September 30, 2024 46.88M
June 30, 2024 46.88M
March 31, 2024 46.88M
December 31, 2023 46.88M
September 30, 2023 46.88M
June 30, 2023 46.88M
March 31, 2023 46.88M
December 31, 2022 46.88M
September 30, 2022 46.88M
December 31, 2013 22.39M
September 30, 2013 22.64M
June 30, 2013 22.64M
March 31, 2013 22.65M
December 31, 2012 23.16M
September 30, 2012 23.18M
June 30, 2012 23.18M
March 31, 2012 23.18M
December 31, 2011 23.18M
Date Value
September 30, 2011 23.18M
June 30, 2011 23.18M
March 31, 2011 23.18M
December 31, 2010 31.18M
September 30, 2010 31.18M
June 30, 2010 31.18M
March 31, 2010 31.18M
December 31, 2009 31.04M
September 30, 2009 31.04M
June 30, 2009 31.04M
March 31, 2009 31.04M
December 31, 2008 30.88M
September 30, 2008 32.10M
June 30, 2008 32.10M
March 31, 2008 31.99M
December 31, 2007 31.90M
September 30, 2007 33.90M
June 30, 2007 33.77M
March 31, 2007 33.61M
December 31, 2006 33.48M
September 30, 2006 33.46M
June 30, 2006 33.29M
March 31, 2006 32.89M
December 31, 2005 32.70M
September 30, 2005 32.56M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Brainstorm Cell Therapeutics, Inc. 11.03M
Summit Therapeutics, Inc. 793.12M
Kezar Life Sciences, Inc. 7.374M
Protara Therapeutics, Inc. 59.08M
Clene, Inc. 12.78M